Seagen (SGEN) Competitors

Biogen (NASDAQ:BIIB) and Seagen (NASDAQ:SGEN) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, community ranking, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.

Does the media prefer BIIB or SGEN?

In the previous week, Seagen had 6 more articles in the media than Biogen. MarketBeat recorded 20 mentions for Seagen and 14 mentions for Biogen. Seagen's average media sentiment score of 1.08 beat Biogen's score of 0.65 indicating that Biogen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Biogen	9 Very Positive mention(s)	4 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Seagen	7 Very Positive mention(s)	5 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive

Which has higher valuation and earnings, BIIB or SGEN?

Biogen has higher revenue and earnings than Seagen. Seagen is trading at a lower price-to-earnings ratio than Biogen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biogen	$10.17B	3.63	$3.05B	$18.37	13.88
Seagen	$1.96B	20.61	-$610.31M	-$3.89	-55.40

Do analysts prefer BIIB or SGEN?

Biogen currently has a consensus price target of $325.36, indicating a potential upside of 27.58%. Seagen has a consensus price target of $190.47, indicating a potential downside of 11.62%. Given Seagen's stronger consensus rating and higher possible upside, research analysts clearly believe Biogen is more favorable than Seagen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biogen	0 Sell rating(s)	5 Hold rating(s)	22 Buy rating(s)	0 Strong Buy rating(s)	2.81
Seagen	0 Sell rating(s)	11 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.35

Is BIIB or SGEN more profitable?

Biogen has a net margin of 26.72% compared to Biogen's net margin of -33.54%. Seagen's return on equity of 17.33% beat Biogen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biogen	26.72%	17.33%	9.51%
Seagen	-33.54%	-26.46%	-20.24%

Do insiders and institutionals have more ownership in BIIB or SGEN?

86.0% of Biogen shares are held by institutional investors. Comparatively, 84.3% of Seagen shares are held by institutional investors. 0.6% of Biogen shares are held by company insiders. Comparatively, 25.9% of Seagen shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Which has more risk and volatility, BIIB or SGEN?

Biogen has a beta of 0.13, meaning that its share price is 87% less volatile than the S&P 500. Comparatively, Seagen has a beta of 0.48, meaning that its share price is 52% less volatile than the S&P 500.

Does the MarketBeat Community prefer BIIB or SGEN?

Biogen received 985 more outperform votes than Seagen when rated by MarketBeat users. Likewise, 72.00% of users gave Biogen an outperform vote while only 63.70% of users gave Seagen an outperform vote.

Company	Underperform	Outperform
Biogen	Outperform Votes 1736 72.00%	Underperform Votes 675 28.00%
Seagen	Outperform Votes 751 63.70%	Underperform Votes 428 36.30%

Summary

Biogen beats Seagen on 14 of the 18 factors compared between the two stocks.